Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$226,179
-$5,554,513 QoQ
Shares Held
2,655
-97.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#359
of 477 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2024CallValue
$1,058,400
CallShares
22,500
PutValue
$493,920
PutShares
10,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. CYTK ranks #202 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in CYTK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,179 | 2,655 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $5,780,692 | 105,180 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $607,869 | 18,398 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $4,174,856 | 103,878 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $1,058,400 | 22,500 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $933,226 | 19,839 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $493,920 | 10,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $733,920 | 13,900 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $227,040 | 4,300 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $5,586,609 | 105,807 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $763,938 | 14,100 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $465,948 | 8,600 | Put | Defined | 2024-08-14 | |
| 2024-03-31 | $1,226,925 | 17,500 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $1,801,827 | 25,700 | Shares | Defined | 2024-05-15 | |
| 2022-12-31 | $751,356 | 16,398 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $4,216,106 | 114,537 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $901,162 | 19,771 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,267,172 | 91,415 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,319,732 | 167,748 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $506,463 | 21,774 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,563,570 | 75,244 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,250,244 | 57,748 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $492,330 | 20,888 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||